BNP Paribas Financial Markets’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,755
| Closed | -$14.7K | – | 3804 |
|
|
2018
Q1 | $14.7K | Buy |
1,755
+1,006
| +134% | +$8.45K | ﹤0.01% | 3381 |
|
|
2017
Q4 | $6.95K | Buy |
749
+400
| +115% | +$3.71K | ﹤0.01% | 3371 |
|
|
2017
Q3 | $4.08K | Sell |
349
-26
| -7% | -$304 | ﹤0.01% | 3402 |
|
|
2017
Q2 | $15.7K | Buy |
+375
| New | +$15.7K | ﹤0.01% | 3232 |
|
|
2016
Q1 | – | Sell |
-638
| Closed | -$26.9K | – | 3331 |
|
|
2015
Q4 | $26.9K | Buy |
638
+32
| +5% | +$1.35K | ﹤0.01% | 3183 |
|
|
2015
Q3 | $33.2K | Buy |
606
+413
| +214% | +$22.6K | ﹤0.01% | 3122 |
|
|
2015
Q2 | $21.2K | Buy |
193
+181
| +1,508% | +$19.9K | ﹤0.01% | 3005 |
|
|
2015
Q1 | $1.14K | Buy |
+12
| New | +$1.14K | ﹤0.01% | 3541 |
|
|
2014
Q4 | – | Sell |
-52
| Closed | -$3.74K | – | 3148 |
|
|
2014
Q3 | $3.74K | Buy |
52
+17
| +49% | +$1.22K | ﹤0.01% | 3346 |
|
|
2014
Q2 | $5.18K | Buy |
+35
| New | +$5.18K | ﹤0.01% | 2106 |
|